Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | G6PD | P11413 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | F9 | P00740 | 1/20 | 0.38 |
| ▸ | F11 | P03951 | 1/20 | 0.38 |
| ▸ | F7 | P08709 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14707935 | 0.94 | HPGD (0.52) | HPGDCYP1A2CYP2A6TAAR1MAPT | |
| SCHEMBL9418558 | 0.92 | LPL (0.43) | HPGDMAPTMEN1GAAKMT2A | |
| SCHEMBL2494547 | 0.88 | CYP1A2 (0.52) | CYP1A2CYP2A6TAAR1MAPTGAA | |
| SCHEMBL402791 | 0.87 | RARB (0.50) | HPGDMAPTMEN1GAAKMT2A | |
| SCHEMBL9664329 | 0.86 | CYP1A2 (0.50) | CYP1A2CYP2A6TAAR1MAPTGAA | |
| SCHEMBL3423042 | 0.85 | LPL (0.48) | HPGDMAPTMEN1GAAKMT2A | |
| SCHEMBL9418464 | 0.85 | FFAR1 (0.45) | HPGDTAAR1MAPTMEN1KMT2A | |
| SCHEMBL13006974 | 0.85 | ALDH1A1 (0.50) | HPGDCYP1A2MAPTMEN1GAA | |
| SCHEMBL8927250 | 0.84 | HPGD (0.50) | HPGDMAPTMEN1GAAG6PD | |
| SCHEMBL14685654 | 0.83 | NPSR1 (0.56) | HPGDCYP1A2TAAR1MAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12384796-B2 | Electroactive compounds | LG CHEM, LTD. (KR) | 2025-08-12 | — | — | US | disclosed |
| WO-2017210072-A1 | ELECTROACTIVE COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2017-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12384796-B2 | Electroactive compounds | NES, NAT1, SCN1B | HPGD 1344/4885CYP1A2 944/4885CYP2A6 182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.